Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12

Find Full text
Publication year
2019
Author(s)
Heitz, F.
Harter, P.
Avail-Lundqvist, E.
Reuss, A.
Pautier, P.
Cormio, G.
Ottevanger, N.
Merger, M.
Bois, A. du
Source
Gynecologic Oncology, 152, 2, (2019), pp. 235-242
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/201794   https://hdl.handle.net/2066/201794
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.